| Ministry of Social Affairs and Health | Finland – Vaccines – Pneumococcal Conjugate (PCV) Vaccine for children and risk groups 202 | €13.8M | 2024-12-02 |
| HUS Group, the joint authority for Helsinki and Uusimaa | Finland – Pharmaceutical products – Nirmatrelviirin ja ritonaviirin yhdistelmävalmisteen ( | €8.0M | 2024-02-28 |
| Ministry of Social Affairs and Health | Finland – Vaccines – Tick-borne Encephalitis (TBE) Vaccine for adults and children 2025 - | €3.2M | 2025-03-20 |
| Pirkanmaan hyvinvointialue | Finland – Medical equipments, pharmaceuticals and personal care products – Nirmatrelviiri/ | €3.0M | 2023-12-21 |
| Terveyden ja hyvinvoinnin laitos | Finland – Pharmaceutical products – Clindamycin / Dalacin 15 mg/ml | €300.0K | 2025-09-10 |